Thaler F, Bernard B, Tod M, Jedynak C P, Petitjean O, Derome P, Loirat P
Intensive Care Unit and Neurosurgery, Centre Medico-Chirurgical Foch, Suresnes, France.
Antimicrob Agents Chemother. 1995 May;39(5):1154-6. doi: 10.1128/AAC.39.5.1154.
We studied fluconazole penetration in the brain in five patients who had a deep cerebral tumor whose removal required the excision of healthy brain tissue. Plasma and brain samples were simultaneously obtained after oral ingestion of 400 mg of fluconazole daily for 4 days (90% of steady state). Fluconazole penetration in healthy cerebral parenchyma was determined. Plasma and brain samples were assayed by high-pressure liquid chromatography. Concentrations in plasma and brain tissue were 13.5 +/- 5.5 micrograms/ml and 17.6 +/- 6.6 micrograms/g, respectively. The average ratio of concentrations in the brain and plasma (four patients) was 1.33 (range, 0.70 to 2.39). Despite the lack of data concerning the penetration of fluconazole in brain abscesses, these results should permit the use of a daily dose of 400 mg of fluconazole in prospective clinical studies that evaluate the effectiveness of this drug in the treatment of brain abscesses due to susceptible species of fungi.
我们对5例患有深部脑肿瘤且肿瘤切除需要切除健康脑组织的患者进行了氟康唑在脑中渗透情况的研究。在连续4天每日口服400mg氟康唑(达到稳态的90%)后,同时采集血浆和脑样本。测定了氟康唑在健康脑实质中的渗透情况。血浆和脑样本通过高压液相色谱法进行分析。血浆和脑组织中的浓度分别为13.5±5.5微克/毫升和17.6±6.6微克/克。脑与血浆浓度的平均比值(4例患者)为1.33(范围为0.70至2.39)。尽管缺乏氟康唑在脑脓肿中渗透情况的数据,但这些结果应能使每日400mg氟康唑剂量用于前瞻性临床研究,以评估该药物治疗由敏感真菌种类引起的脑脓肿的有效性。